Intelligence Platform
Patents
Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7744934
Methods for modulating eicosanoid metabolism
granted patentUS 7744851
Methods and agents for preparing 18F-radiolabeled fluorinating agents
granted patentUS 7741091
Methods of producing hyaluronic acid and chimeric and hybrid glycosaminoglycan polymers
granted patentUS 7740867
Method for identification of virulence determinants
granted patentUS 7737266
RNAi modulation of SCAP and therapeutics uses thereof
granted patentUS 7736646
Methods for modulating angiogenesis with apelin compositions
granted patentUS 7732470
Compositions and methods for the treatment of renal and cardiovascular disease
granted patentUS 7732576
Tumor suppressor designated TS10Q23.3
granted patentUS 7727554
Sustained-release nanoparticle compositions and methods for using the same
granted patentUS 7723375
Metabolites of wortmannin analogs and methods of using the same
granted patentUS 7723104
Cancer specific promoters
granted patentUS 7718387
Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using E
granted patentUS 7718160
Radiolabeled compounds and liposomes and their method of making and using same
granted patentUS 7714007
Method of alleviating chronic pain via peripheral glutaminase regulation
granted patentUS 7714109
Combinations and kits for cancer treatment using selected antibodies to aminophospholipids
granted patentUS 7713934
Thrombin peptide derivatives
granted patentUS 7709190
Influenza A virus vaccines and inhibitors
granted patentUS 7709643
Synthesis of sodium narcistatin and related compounds
granted patentUS 7709625
Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes fo
granted patentUS 7709456
Modulation of gene expression by oligomers targeted to chromosomal DNA
granted patentUS 7704962
Small oligonucleotides with anti-tumor activity
granted patentUS 7705188
Structural modification of resveratrol: sodium resverastatin phosphate
granted patentUS 7704985
Treatment of irritable bowel syndrome and related bowel diseases
granted patentUS 7704497
Molecules with extended half-lives, compositions and uses thereof
granted